Market Research Blog – Page 14610 – New Product Development

Microparticle Injectables Market 2022 Key Players, End User, Demand and Consumption by 2031

According to the latest research by FMI, Microparticle Injectables are set to witness a steady-paced growth of CAGR 5.8% during the year 2021-2031. Microparticle Injectables are broadly used constituents of multiparticulate drug delivery systems, offering both technological and therapeutic advantages. The applications of microparticle injectables as drug delivery systems allow for a controlled delivery of active pharmaceutical ingredients in the body.

The long-lasting delivery of such API over a time period of weeks, or a couple of months as microparticle injectables increases patient benefits as well as is responsible for the reduction of burden of compliance among the patients. The demand of microparticle injectables as a means for drug delivery is set to increase steadily over the forecast period. This demand is driven primarily on the basis of lower degradation event associated with the API, which in turn leads the drug to have potentially lower side effects.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14106

What is Driving Demand for Microparticle Injectables?

The demand for microparticle injectables is driven mainly through their benefits revolving around patient compliance. Apart from providing abundant patient benefits, the microparticle injectables also deliver drugs directly into the blood stream or the initiated local environment. The efficacy of this process evades hepatic and gastric degradation of the API.

The effectiveness of microparticle injectables as long-acting dosage forms also drive the key market players to benefit from developing novel drug dosage formulations and generate profitable revenue. Furthermore, several microparticles are not required to be removed later through surgical operation, because of the use of biodegradable materials in their formulation.

Which factors are likely to augment growth of Microparticle Injectables?

The microparticle injectables are emerging in terms of their biomedical applications in the field of cardiology, neurology as well as gastrology. The augmentative factors responsible for the growth of adoption of microparticle injectables over the globe are their ability to treat a range of indications such as CNS disorders and cancer. Rising demand for bioresorbable polymers and their efficient use in commercialization are further set to increase the demand of microparticle injectables over the forecast period.

U.S. and Canada Microparticle Injectables Outlook

The region of North America is expected to grow at a significant rate over the forecast period. The factors aiding this growth are the presence of key and leading market players in the region in addition to a developed healthcare infrastructure as well as advanced biopharmaceutical production processes in the region.

In 2021 alone, the U.S. FDA and the European Medicines Agency (EMA) approved more than 15 drugs based on microparticles made of biodegradable polymers such as poly (lactide) (PLA) and poly (lactide-coglycolide) (PLGA), which possess biocompatible properties. The rising research activities as well as production of novel drug dosage formulations in the region account for the highest sales value share in the market over the forecast period.

Europe Demand Outlook for Microparticle Injectables

The region of Europe is anticipated to occupy a large share after North America in the adoption of microparticle injectables due to the rising prevalence of chronic diseases in the region, as well as increasing technological advancements.

The growth is also evaluated by the presence of growing advancements in healthcare and research in the region. According to the WHO, about 50 million people in the region of Europe suffer from more than one chronic disease.

Who are the Key Manufacturers and Suppliers of Microparticle Injectables?

The key companies operating in manufacturing and supply of microparticle injectables are

Lubrizol Life Science
Baxter International Inc
Sandoz
Eli Lilly and Company
Pfizer Inc.
Evonik
Oakwood Labs and GP Pharm.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14106

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Microparticle Injectables market Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Key Segments

By Therapeutic Application:

Chronic Diseases
Autoimmune Diseases
Hormone Related Disorders
Oncology
Others

By Administration Site:

Central Nervous System
Skin
Musculoskeletal
Targeted Organs

By Distribution Channel:

Medical Hospital Pharmacy
Retail Pharmacy

By Region:

North America
Latin America
Europe
South Asia
East Asia
Middle East and Africa

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/14106

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Long-Acting Monoclonal Antibodies Market 2022 Key Players, SWOT Analysis, Key Indicators and Forecast to 2031

According to the latest research by Future Market Insights, the Long-Acting Monoclonal Antibodies market will undergo a steady growth during 2021-2031. A gradual increase due to constant research studies being conducted and new verticals of disease treatment being opening can be seen over the mentioned forecast period. The increasing innovations and advancements in genetic engineering will further boost the market. Current Pandemic situation of Covid-19 has made the market to grow immensely in the field of developing more vaccines at the global rate of the population.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14105

What is driving Demand for Long-Acting Monoclonal Antibodies Market?

The demand for long-Acting monoclonal antibodies market has seen at a higher rate at a global level as there has been increase in the number of chronic diseases growing at a different level. The rising ageing population and sedentary lifestyle owes for the demand for the market. Furthermore, long-acting monoclonal antibodies market has witnessed significant positive impact of COVID-19 as several mAbs have potential to effectively treat coronavirus infection. The companies are also conducting clinical trials to further boost the development of highly potential therapies. With potential in minimizing infection severity in treatment of COVID-19, the industry will continue to experience revenue growth during the pandemic. Alternating therapeutics market is exploring themselves globally.

Increasing Product Launches and Approvals to boost the Demand

Monoclonal Antibodies are the similar immunoglobulins which is developed from a B-cell. New technological advancement has brought in benefiting results via research and development industries. FDA has approved many monoclonal antibodies giving the lucrative growth in the given forecast period. FDA issued the EUA i.e. emergency use authorization for Casirivimab and imdevimab that can be used in treating mild to moderate infection.

U.S. Long-Acting Monoclonal Antibodies Market Outlook

U.S. is said to be the most dominating market due to its well-developed health infrastructure, in terms of disease treatment rate. Leading industries in the US has seen to expand themselves into long acting monoclonal antibody market. The presence of major players and ongoing clinical trials makes U.S. the leading player in the market. For instance, ASTRAZENECA’s long acting antibody is set to enter into phase 3 of clinical trial.

Europe Demand Outlook for Long-Acting Monoclonal Antibodies Market

The European market is considered to be the second largest market for long-acting monoclonal antibodies at a global level. As technological advancement grows, it will directly lead to rise in the monoclonal antibody market size. This market is seen to grow at a rapid pace as oncological segment constitutes a high demand for production. Furthermore, European Medicine Agency in the year 2013 approved of biosimilar products and said that they can be approved globally, which in turn drives the market demand. R&D are expanding themselves in developing new drug every now and then, this will let the antibody market to reach heights.

Who are the Key Manufacturers and Suppliers of Long-Acting Monoclonal Antibodies market

Eli Lilly
Abbott Laboratories
AstraZeneca plc.
Amgen Inc.
Bayer AG
Johnson & Johnson
Pfizer
GlaxoSmithKline Plc.
Merck & Co. Inc.
Novartis

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14105

Long-Acting Monoclonal Antibodies Market Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Key Segment

By Source Type:

Murine
Chimeric
Humanized
Human

By Indication:

Cancer
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Others

By End User:

Hospitals Pharmacies
Drug Stores
Retail Pharmacies
E-commerce

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/14105

Contact Us:

UV Tapes Market Share and Growth Factors Impact Analysis 2020

Future Market Insights (FMI), in its recent report titled, “UV Tapes Market : Global Industry Analysis and Opportunity Assessment 2015 – 2020”, projects that the global UV Tapes market will exhibit a CAGR of 9.3 % during 2015 to 2020.

UV tapes are a type of pressure-sensitive tapes with high adhesion strength, which reduces drastically on exposure to UV light, thereby allowing clean and easy removal of semiconductor chips after it has fulfilled its purpose. During fabrication, storage, and shipping of semiconductor wafers, these tapes temporarily protect wafers against scratching and surface damage. These are produced from PVC, PET, or PO backing material with acrylic adhesive to hold pieces of semiconductor (dies) in place. These tapes are generally thinner as compared to other tapes, which vary from between 70 to 150 micrometers.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-435

The report analyses the global UV tapes market in terms of market value (US$ Mn) by applications, region and product type and provides information regarding market dynamics, value chain, competitive landscape, current trends, market estimations and forecast.

As of 2014, UV tapes accounted for less than 1% of the global PSA tapes market in terms of volume and value. Increase in demand for consumer electronics coupled with miniaturization of electronic devices is driving the demand for semiconductors that leads to growing demand for UV tapes. Various governments in Asia Pacific are focusing on sustainable development and have formulated the regulations for same. These regulations and initiatives are identified as underlying driving factors of the market. On the flipside, high cost of UV tapes than non-UV tapes is a minor restraint in the UV tapes market.

From regional perspective, Asia Pacific and North America represented prominent markets for global UV tapes market in 2014. In terms of market value, Asia Pacific is projected to account for 5.4X higher revenue than North America by the end of forecast period 2020. Presence of large scale semiconductor foundries in Asia Pacific is the prime reason behind the surge in demand for UV tapes in this region. Asia Pacific is expected to be the largest market for UV tapes in terms of value, followed by North America and Europe.

Browse Full: “UV Tapes Market : Global Industry Analysis and Opportunity Assessment 2015 – 2020” Market Research Report at https://www.futuremarketinsights.com/reports/details/uv-tapes-market

From product type perspective, polyolefin-based UV tapes are expected to register highest CAGR followed by polyvinyl chloride (PVC) and polyethylene terephthalate (PET). While polyolefin-based UV tapes are projected to be the largest market segment by the end of forecast period, PVC is anticipated to witness 1.5X growth in its revenue by the end of forecast period.

From application type perspective, UV tapes market has been segmented into wafer dicing, back-grinding and others. Wafer dicing and back-grinding are two subsequent procedures applied in semiconductor processing. It is due to this that UV tapes in both application account for nearly same market share, however both are projected to lose market share to other applications that include aerospace and telecommunication. Wafer dicing and back-grinding are expected to exhibit a CAGR of 9.2% during the forecast period.

Purchase the Report : https://www.futuremarketinsights.com/checkout/435

Key market participants covered in the report include UV tape manufacturers and raw material suppliers. Furukawa Electric Co., Ltd. Nitto Denko Corporation, Mitsui Chemicals, Lintec Chemicals, and Sumitomo Bakelite Co. Ltd. are key manufacturers, while BASF SE, Henkel AG & Company and Dow Chemical Co are some of the key raw material suppliers covered under this research report.

Home Infusion Therapy Devices Market Research Report 2022 – Global Forecast till 2031

According to a recent study by Future Market Insights (FMI), sales of home infusion therapy devices are expected to top US$ 2.0 Bn in 2021, growing at a CAGR of over 6.5% during the forecast period (2021-2031).

Home infusion therapy devices are used for the intravenous administration of medicines. It is commonly prescribed for patients with serious infections and specialized diseases when orally administered medicines are not or comparatively less effective.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13974

Application of home infusion therapy devices is increasing with the rising number of surgeries conducted across the globe. Post-surgery pain management at home can be done with the help of home infusion therapy devices.

home infusion therapy devices market characteristics and attributes with regional relevance 2021

Besides this, rising healthcare expenditure and growing awareness regarding the risk and infection amidst the outbreak of COVID-19 is driving the demand of home infusion therapy devices.

Key Takeaways from Home Infusion Therapy Devices Market Study

By product type, infusion system accessories will hold around 45% of value share globally.
Based on the application, antibiotic administration is leading with over 34% of the market share.
Home care settings sales will dominate the home infusion therapy devices, with a market share of 65% during the forecast period.
By region, the U.S. will dominate the global home infusion therapy devices market with a value share of around 37% during the forecast period.
Followed by North America, Europe will be the second-largest leading region, with a value share of 93.2% during the forecast period.
India is the dominant country in term of revenue for South Asia Home infusion therapy devices market, accounting for nearly 48% of market share in 2021.
China holds leading position in East Asia and is expected to account for nearly 52% of market share.

“Growing prevalence of chronic diseases such as diabetes and cancer in the midst of COVID-19 pandemic and high risk of infection across hospitals encouraged key players to invest in new product launches. This is expected to enable growth in the market in the coming years” says a FMI Analyst.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-13974

Who is Winning?

Key players are focusing on new product launches and approvals. Other growth strategies adopted by leading players include, agreements, and collaborations among key manufacturers. By focusing on these strategies, key players are expanding their geographic presence and strengthening their existing product portfolio.

For instance,

In June 2019, Baxter International Inc. announced that Myxredlin that is the first and only ready-to-use insulin for IV infusion get the US FDA approval.
In Jan 2019, Fresenius Kabi AG launched two colourful bags via white spiral cables to supply the nutrient solution for parenteral nutrition.
In April 2017, B. Braun Melsungen AG announced the launch of home infusion therapy App named Easypump® for healthcare professionals and patients.

The key market players profiled by FMI include Becton, Diciknson & Company, B.Braun Melsungen AG, Baxter International, Fresenius Kabi, Terumo Corporation, ICU Medical, Nipro Corporation, Smiths Medical, Micrel Medical Devices SA, Moog Inc., JMS Co.Ltd., Intera Oncology, and Others Top-up.

Home Infusion Therapy Devices Market by Category

By Product Type:

Disposable Elastomeric Pumps
Insulin Pumps
PCA Pumps
Electronic Ambulatory Pumps
Infusion System Accessories

By Applications:

Enteral Nutrition
Parenteral Nutrition
Chemotherapy
Antibiotic Administration
Others

By End User:

Home Care Settings
Long Term Care Centers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/13974

Key Questions Answered in the Report

How much is the home infusion therapy devices market worth?
What is the demand outlook of the home infusion therapy devices market?
What are the key trends shaping home infusion therapy devices market?
What is the market share of the top players in the home infusion therapy devices market?
Which are the top 5 countries driving demand for home infusion therapy devices?
At what rate will the sales of home infusion therapy devices rise in Europe?
What is the outlook for home infusion therapy devices market in East Asia?
Which companies are key producers of home infusion therapy devices?

Contact Us:

Automotive Interior Leather Market is valued at US$ 29.9 Bn in 2021 expected to grow at a CAGR of 4.1% during 2021-2031

Globalization of the automobile industry and rising demand for automotive interior customization are expected to remain chief driving factors of the global automotive interior leather market. According to Future Market Insights (FMI), the global automotive interior leather market is estimated to be valued at ~US$ 29.9 Bn in 2021.
The COVID-19 pandemic crisis has severely affected the global economic growth, resulting in disruptions in the supply chain networks. Subsequently it has affected the market leading to sluggish growth in 2020. However, the market is expected to recover as economic activities resumes post the containment of pandemic.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1561
According to FMI, sales within the passenger cars segment will recover after taking a massive hit amid COVID-19 in 2020. Despite this, temporary period of lull passengers will account for a little below 70% of leather sold for automotive interior in 2021.
The research examines prevailing demand and supply trends within the automotive interior leather. It presents a comprehensive overview based on in-depth research. Some of the key findings of the report are discussed below:

Key Takeaways of Global Automotive Interior Leather Market Study
• Automotive interior leather market is expected to expand at a CAGR of ~4.1% during the forecast period of 2021-2031
• The U.S. will account for over 84% of automotive interior leather sold in North America
• The U.K. is expected to register above 4% Y-o-Y growth in 2021 after witnessing significant drop in sales in 2020
• Germany and France will exhibit positive growth after registering negative sales amid COVID-19
• Within East Asia, China will remain the dominant market, trailed by Japan and South Korea

“Manufacturers are focusing on product innovation and besides offering improved sustainability. In the coming years they are likely to gain from the rising demand for passenger cars. Also, consumers’ preference for the sustainable products and better comfort are the key factors enabling growth in the market. Overall the expansion of the automotive industry will continue creating lucrative opportunities for the market,” said an FMI analyst.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1561

Some of the key players in the market are Lear Corporation, Seiren Co., Ltd, GST AutoLeather Inc, BOXMARK Leather GmbH & Co KG, Bader GmbH & Co. KG, Katzkin Leather,Inc. , Leather Resource of America, WOLLSDORF LEDER SCHMIDT & Co. Ges.m.b.H. , DK Leather Corporation, Scottish Leather Group Limited. These players have comparatively higher market presence in the global market, and have longstanding relationships with a number of leading end users, giving them an upper hand among their peers.

Global Automotive Interior Leather Market by Category
Material Type
• Genuine Leather
• Synthetic Leather
• PU Leather
• PVC

Vehicle Type
• Passenger Cars
• Compact
• Mid-Sized
• Sedan
• Luxury
• Van
• Light Commercial Vehicles
• Heavy Commercial Vehicles

Application
• Upholstery
• Dashboard
• Seat belts
• Air-bags
• Floor & trunk carpets
• Headliners
• Others

Sales Channel
• OEM
• Aftermarket

Get Full Report Now @ https://www.futuremarketinsights.com/reports/automotive-interior-leather-market

Key Questions Answered in the Report
• Which is the most lucrative market for Automotive Interior Leather? China currently leads the global market for automotive interior leather. Sales in China will be over one fifth of total demand throughout the forecast period.
• Which are the top-selling Automotive Interior Leather material type? Synthetic leather is highly sought-after in vehicle production. The demand for PU leather is expected to remain high in the near future, especially due to its increasing use across passenger vehicles.
• Which Vehicle Type is Exhibiting high demand for Automotive Interior Leather? Automotive interior leather is widely used in passenger cars. Its usage in compact and luxury cars is anticipated to remain key factor impacting the overall market growth.

Top Reports Related To Automotive Market Insights
Ship Repair and Maintenance Services Market: https://www.futuremarketinsights.com/reports/ship-repair-and-maintenance-services-market
Ship repair and maintenance services market is set to be valued at US$ 44.3 Bn, expanding at 6.5% CAGR through 2031, according to latest research conducted by Future Market Insights (FMI).

Ultra-High Performance (UHP) Tire Market: https://www.futuremarketinsights.com/reports/ultra-high-performance-tire-market
The global UHP tires market is projected to reach a valuation of US$ 10.41 Bn in 2021. Increasing demand for high performance vehicles in the automotive sports sector is expected to push sales of UHP tires at 10.9% CAGR, with the market valuation reaching US$ 23.32 Bn in 2031.

Textile Chemicals Market Size, Share, Growth Trends, and Forecast Analysis to 2031

ESOMAR-certified consulting firm Future Market Insights’ report, projects the global textile chemicals market to exhibit growth at 5.40% CAGR over the forecast period of 2021 and 2031.

Growing demand for non-toxic chemicals from apparel industry is accelerating textile chemicals sales across the globe. Key players are therefore investing heavily in research & development for the development of eco-friendly non-toxic chemicals to cater the demand within textile & apparel industry.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-434

Development of chemicals that reduces the water consumption in textile production and processing will aid the demand of textile chemicals across China, India and Vietnam, bolstering growth.

As per the FMI’s analysis, due to the unprecedented outbreak of Covid-19, textile chemicals market sales declined, registering sluggish growth at 1% CAGR during 2016-2020. However, burgeoning demand for PPE kits and mask across the globe improved the supply-chain of textile chemicals across China, India and Japan.

FMI forecasts, South Korea and Japan, collectively, accounted for around 12% global market share backed by the burgeoning demand within apparel industry in 2021.

According to the FMI’s analysis, the global Textile chemicals market reached a valuation of US$ 22,126.3 Mn in 2021.

Key Takeaways from FMI’s Textile chemicals Market Study

By application type, apparel segment will lead the global textile chemicals market over the forecast period.
In terms of product type, textile auxiliaries will retain its dominance, witnessing high single digit growth during the forecast period
Finishing process will be the most preferred process among textile chemicals manufacturers, registering a growth of 10.6% CAGR
Japan will emerge as the leading market across North America backed by the high demand within the textile & apparel industry
India will emerge as the most lucrative market registering fastest growth in terms of value over the forecast period
China is anticipated to lead the East Asia’s Textile chemicals market, exhibiting the growth at 10.6% CAGR

“Increasing sustainability approach for reduced water consumption and adoption of non-toxic chemicals are fuelling the demand from apparel industry. This has in turn strengthened growth opportunities for the market players,” says the FMI analyst.

Purchase the Report : https://www.futuremarketinsights.com/checkout/434

Competitive Landscape

Huntsman Corporation, Archroma Management LLC, Evonik, Kemira, Solvay, Lonsen, CHT Group and DyStar Group among others are some of the key players profiled in the textile chemicals market.

As per the FMI’s analysis, the market is dominated with top 5 players operating in Textile chemicals market, accounting for around 20-25% of market share.

Key players are adopting sustainable approaches to strengthen their position in the industry while adhering to the stringent regulations for textile chemicals laid down by government.

Long-term agreements with apparel industry stakeholders and targeted mergers & collaboration to improve the revenue generation will be one of the key strategy adopted by industry players.

For instance, Department of Textile Engineering, University of Engineering and Technology (UET), in May 2021, announced the launch of the textile sustainability working group to conduct training and seminars, mill assessment related to energy conservation and sustainability research & development projects.

In July 2019, Achitex Minerva announced the acquisition of the corporate assets of Minerva Color Columbiana for the expansion of the market structure of Achitex Minerva Colombia LTD, in Bogota

Needle-Free Injectors Market 2022 | Present Scenario and Growth Prospects 2031

According to a latest study by Future Market Insights (FMI), global needle-free injectors’ sales are expected to reach US$ 12.3 Bn in 2021, surging at 11.4% CAGR during the forecast period (2021-2031).

Needle-free injection is an innovative drug delivery technology that drives drugs to the skin using force which virtually nullifies the use of hypodermic needle. With growing preference for non-invasive drug delivery system and vaccines, adoption of needle-free injectors is expected to improve over the coming years

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13960

Application of needle-free injectors is increasing with rising incidence of diabetes and other chronic diseases across the globe. With increasing number of surgeries, demand for minimally invasive procedures is accelerating the sales of needle-free injectors.

According to Centers for Disease Control and Prevention (CDC), more than 51% of adults in U.S. had at least 1 chronic condition, and 27.2% had multiple chronic conditions in 2018.

Other factors driving the global demand are cost-effectiveness and safety related to needle-free injectors.

Key Takeaways from Needle-free Injectors Market study

By load type, liquid injections segment will hold around 88.0% of value share globally.
Based on the technology, spring-loaded jet injector is dominating the market, with over 48.0% of the market share.
Based on the delivery site, intra dermal injector is expected to hold over 33% of the market share.
Application of drug delivery will spur the sales of needle-free injectors, with the segment accounting for 65% of the market share.
Based on the usage, reusable needle free injectors are highly sought-after, contributing over 78% of the market revenue.
Hospitals are expected to be the primary end-users, holding a market share of 28% during the forecast period.
By region, North America will dominate the global needle-free injectors market, holding 42% of total market share.
Europe is expected to be the second-largest market, with Germany spearheading the market growth .
India will emerge as the most lucrative market across South Asia, accounting for nearly 50% of market share in 2021.
China will hold leading position in East Asia and is expected to account for nearly 46% of market share.

“Growing prevalence of chronic diseases coupled with rising preference of non-invasive drug delivery system will improve the adoption of needle-free injectors. With rising demand for needle-free injectors, key players are introducing new product launches and are aiming for fast track approvals to capitalize on existing opportunities and sustain their position in the industry “says the FMI Analyst.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-13960

Who is Winning?

New product launches and approvals, agreements, and collaborations are some of the key growth strategy adopted by the key players. By focusing on these strategies, key players intend to expand their global presence and strengthen their existing product portfolio.

For instance,

In November 2019, Antares Pharma collaborated with Idorsia for the development of a novel self-administered drug-device product.
In June 2020, Vitaeris Inc., a biotech company was acquired by CSL Limited. The acquisition was carried out by CSL Limited to achieve the motive of addressing the unmet needs of patients.

The key market players covered by FMI include Pfizer, Inc., Gerresheimer AG, Ferring Pharmaceuticals, CSL Limited (Seqirus UK Limited) and others.

Needle-free injectors Market by Category

By Load:

Liquid Injections
Powder Injections
Projectile Injections

By Technology:

Spring-loaded jet injector
Battery-powered jet injector
Gas-powered jet injector

By Delivery Site:

Intra dermal injectors
Intramuscular injectors
Subcutaneous injectors

By Application:

Drug Delivery
Vaccines
Cosmetic
Others

By End User:

Home Care Settings
Long Term Care Centers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/13960

Key Questions Answered in the Report

How much is the needle-free injectors market worth?
What is the demand outlook of the needle-free injectors market?
What are the key trends shaping the needle-free injectors market growth?
What factors are driving demands for needle-free injectors?
Which are the top 5 countries driving demand for needle-free injectors?
At what rate will the sales of needle-free injectors increase in Europe?
At what rate will the demand for needle-free injectors rise in East Asia?
Which companies are key producers of needle-free injectors?

Contact Us:

Vacuum Blood Collection Devices Market 2022 Development Status, Competition Analysis, Type and Application 2031

According to a recent study by Future Market Insights (FMI), the global vacuum blood collection devices market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 2.2 Bn in 2020 to over US$ 2.3 Bn through 2021. It also is expected to register cumulative CAGR of around 6.3% over the forecast period (2021-2031).

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5363

Vacuum blood collection devices are closed tubes for blood collection and thus reduces the direct exposure of blood to the environment thus lowering risk of contamination. These tubes have improved sampling by allowing sample collection through single venipuncture. Ease in the process of blood collection, processing and the lowering risk of contamination to the patients are the major factor driving the market growth.

Global burden of chronic diseases such as, cardiovascular disorders, cancer, and diabetes has increased at a rapid pace. High prevalence of these diseases has enforced adherence to the regular health checkups and growing importance of markers for early diagnosis via blood tests.

As blood tests are primary mode of diagnosis for these diseases, the rise in number of chronic diseases will positively drive the demand for vacuum blood collection devices, augmenting the market growth.

Rising advancements in the field of biotechnology have enabled the establishment of several non-invasive approaches for disease diagnosis. Amongst other favorable diagnostic tools, liquid biopsy has emerged as a promising and versatile non-invasive cancer diagnostic tool. Liquid biopsy analysis based on circulating cell-free nucleic acids, circulating tumor cells or other diseased cells from organs, and exosomes or other micro vesicles in blood offer new means for non-invasive diagnostic applications.

With growing number of stabilizing reagents and dedicated vacuum blood collection tubes available in the market, it has become possible to perform the post-collection preservation of circulating cell-free DNA (cfDNA) profiles in whole blood.

This has certainly increased the demand for non-invasive diagnostic procedures. Such advancements are expected to provide lucrative growth opportunities for the vacuum blood collection devices market.

Key Takeaways from Vacuum Blood Collection Devices Study

By product, serum separator tubes will account for the largest share of 23.2% in 2021, and is expected to remain dominant throughout the forecast period.
Based on material, plastic/PET material will hold mammoth’s share of 84.5% in 2021
In terms of application, routine chemistry is expected to account for the largest share of 34.2% in 2021 of vacuum blood collection devices market and is expected to continue to grow at the same trend during the forecast period.
Diagnostic laboratories are expected to be the primary end-user of vacuum blood collection devices, holding total market share of 46.6% in 2021
The U.S. is expected to emerge as the most lucrative market across North America, capturing 87.3% of market share.
India will lead the growth of South Asia’s vacuum blood collection devices market, contributing for over 74.6% of sales through 2031

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5363

“Growing awareness regarding health and increasing health checkups due rising prevalence of lifestyle & chronic disorders is expected to fuel the demand of vacuum blood collection devices over the decade,” says the FMI Analyst

Who is Winning?

Some of the leading manufacturers of vacuum blood collection devices market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

In February 2021, Greiner Bio-one introduced Vaccuate FC Mix Tube that provides effective glycolysis inhibition for precise determination of the in vivo blood sugar content.
In November 2020, Intervactechonlogy OU introduced new packaging system for its blood collection devices set. This packaging sets are available for pack of 1, 2, and 5 tube pack.
In June 2018, Poly Medicure acquired Plan 1 Health S.R.L., one of the prominent medical device player operating in Italy. This acquisition will help company to expand its geographical reach as well as enhance its portfolio in the medical device industry region. Further, as per agreement, Plan 1 Health S.R. L. will now operate as a subsidiary of Poly Medicure B.V, and indirect subsidiary of Poly Medicure Limited.
In December 2017, Becton, Dickinson, and Company (BD) acquired C.R. Bard, Inc. As per the agreement, followed by acquisition C.R. Bard will operate as a wholly owned subsidiary of BD. Further, this acquisition, enabled company to expand their foot print I the global Life science, and medical devices segment.

The key market players covered by FMI include Becton, Dickinson, & Company, Greiner Bio-One GmbH, Guangzhou Improve Medical Instruments Co.,Ltd, AB Medical, Inc., SARSTEDT AG & Co. KG, Cardinal Health, Poly Medicure Ltd, FL Medical , InterVac Technology, CHENGDU RICH SCIENCE INDUSTRY CO., LTD., Zhejiang Gongdong Medical Technology Co., Ltd., Aptaca Spa., Hindustan syringes & Medical Devices.

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/5363

Contact Us:

Headspace Gas Analyzers Market 2022 | Scope of Current and Future Industry 2031

According to a recent study by Future Market Insights (FMI), the global headspace gas analyzers (HGA) market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 60.8 Mn in 2020 to over US$ 152.8 Mn by 2031. This reflects a cumulative CAGR of around 8.8% over the forecast period (2021-2031).

Increasing demand for in-process monitoring to keep an eye on various quality parameters of headspace analyzer such as container closure integrity (CCI), oxygen content, and moisture content is expected to push sales of headspace gas analyzers in the near future.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13979

Recently, regulatory requirements for sterile pharmaceuticals have been increasingly focused on CCI. Numerous new drug items and container systems have been released to the market. In the various stages of the product package life cycle, appropriate level of CCI verification and HGA is advised.

Headspace gas analyzers methods eliminate all the destructive inspections’ limitations, allowing for a targeted, objective, holistic evaluation of the entire production and ensure the product stability.

They also provide sterility throughout the product life cycle, research and validation, normal manufacturing, and the marketed product scenario. As a result, a change in the rules for the use of headspace gas analyzers in the pharmaceutical and other industries is likely to increase the demand for these devices.

Technological advancement and new product launches & approvals have emerged as key growth strategies adopted by the leading players in the headspace gas analyzers market. By adopting these strategies, companies are aiming to expand their regional presence as well as product offerings.

For instance, in July 2021, the CCI laboratory tester NEO DPX by WILCO AG was honoured with the Good Design Award 2020 in the industrial category by the Chicago Athenaeum Museum of Architecture and Design.

In June 2019, WILCO AG developed an individual system design in six phases for the visual inspection of parenteralia in various packaging materials to achieve the greatest possible reliability of the inspection results.

Such developments not only strengthens the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and helps companies to sustain the increasing competitive pressure.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-13979

Key Takeaways from Headspace Gas Analyzers Study

By product, oxygen headspace analyzers will hold maximum share of more than 45% in 2021.
In terms of modality, benchtop system of headspace gas analyzers are expected to account for over 60% of the market share in 2021 owing to the extreme stability and accuracy in the inspection of overfilled containers with limited headspace.
By end user, the hospitals will account for over 40% of the market share in 2021 owing to the rising demand for sterile products and increasing percentage of health problems by unhygienic food packaging.
North America is expected to hold nearly 40% of global market share in 2021 on the back of rising product adoption, increasing demand for packaging of pharmaceutical products, health consciousness, and increasing disposable incomes

Increasing demand for sensitive sterile pharmaceutical products and technological advancements in headspace gas analyzers are expected to push growth over the forthcoming decade, says the FMI Analyst

Who is Winning?

Some of the leading manufacturers of headspace gas analyzers market are focusing on product launch, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

In June 2021, CS Analytical Laboratory installed LIGHTHOUSE’s Instruments Suite with laser-based headspace capabilities for container closure integrity testing.
In July 2019, Labthink launched a commemorative innovative product, C130H Gas Permeation Test System, a high-precision laboratory testing instrument based on a differential pressure method, to help realize gas permeability, solubility coefficient, and diffusion of thin films and sheets in fields of scientific research, food, pharmaceuticals, packaging materials, and many others, to efficiently enhance product quality control and new product R&D processes.
In July 2017, Illinois Instruments collaborated with OxySense, a leading brand in non-invasive optical oxygen analyzers and permeation testing solutions. OxySense and Systech Illinois had been trusted for decades for delivering the highest quality and most reliable gas measurement solutions.

The key market players covered by FMI include WILCO AG, Quantek Instruments Inc., Illinois Instruments Inc., Labthink International Inc., LIGHTHOUSE, GASPOROX AB, Xepics SA, Bonfiglioli Engineering S.r.l.

Headspace Gas Analyzers by Category

Product:

Oxygen Headspace Analyzers
Carbon Dioxide (CO2) Headspace Analyzers
Combination Headspace Analyzers
Pressure/Moisture Headspace Analyzers

Modality:

Benchtop Systems
Handheld Headspace Analyzer

End User:

Research & Development Facilities
Contract Manufacturing Organizations
Pharmaceuticals Manufacturing
Clinical Trials Agencies

Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/13979

Key Questions Answered in the Report

What is the demand outlook for the global headspace gas analyzers market?
Which is the most lucrative market for headspace gas analyzers market?
What factors are driving demand for the headspace gas analyzers?
What are the key market statistics in South Korea and Japan?
What are the top 5 countries driving demand for headspace gas analyzers market?
Which are leading companies of headspace gas analyzers market?

Contact Us:

Rough Terrain Cranes Market projected to grow at a promising CAGR of 5.6% through 2026 : FMI

[128 Pages Report] The rough terrain cranes market is set to grow at CAGR of 5.3% through 2026.Middle East Africa is the largest market of rough terrain cranes market. The market will reach US$ 240 Mn by 2026. 25T – 50T is the largest segment in rough terrain cranes market and is set to grow at 26.2% through 2026.The latest market outlook titled “Rough Terrain Cranes Market: Middle East and Africa Industry Analysis and Opportunity Assessment, 2016–2026” by Future Market Insights offers imperative insights into the Middle East and Africa rough terrain cranes market for the forecast period 2016-2026.

The overall long-term outlook on the growth of MEA market for rough terrain cranes remains optimistic, with the market projected to grow at a promising CAGR of 5.6% through 2026. Over the assessment period, MEA market for rough terrain cranes will gain nearly 100 BPS, reaching a market size of over US$ 231 Mn by 2026 end. GCC countries currently account for a significant share of the MEA market – this will remain the trend throughout the forecast period. The next largest markets include South Africa, Israel, and Turkey, which is anticipated to be closely followed by the rest of MEA.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-ma-2571

Key research findings strongly influencing the market growth

High initial capital and expensive maintenance continues to fuel preference for rental cranes over new crane sales.
Lucrative opportunities abound in the high lifting capacity cranes i.e. > 100T capacity segment.
Application in fracking pipe yards, transmission distribution lines, and tank firms will unlock new revenue generation opportunities.
Implementation of automation and advanced telematics are identified to be the top influential developments.
Focus on enhanced operator comfort and efficient fuel economy underpins introduction of new features in rough terrain cranes.
GCC will remain the largest market in rental as well as new sales of rough terrain cranes within MEA.
Maximum new sales will be registered in Turkey over 2016-2026.
African countries will account for significant demand owing to rapidly developing power generation and distribution infrastructure, and burgeoning mining activities.

The market has been segmented for in-depth analysis over 2016-2026, into MEA rough terrain cranes market – new sales and MEA rough terrain cranes market – rental. While market for rental rough terrain cranes is likely to witness a CAGR of 5.3% reaching a value worth US$ US$ 247.4 Mn in 2026, market for new sales of rough terrain cranes is expected to reach US$ 142.0 Mn by 2026-end, expanding at a healthy CAGR of 5.9% over the assessment period.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-ma-2571

MEA Rough Terrain Cranes Market – Rental

Future Market Insights expects this market to reach US$ 248 Mn in 2026.

On the basis of lifting capacity, the highest growth will be observed in > 100 tonnes capacity segment.
50-75T capacity segment will continue to dominate the market throughout the forecast period.
75-100T capacity segment will possibly exceed revenues of US$ 68 Mn in 2026, accounting for more than 27% share of the entire market revenues at the end of forecast period.
By boom length, 25-35 metre segment is projected to remain dominant with a major revenue share contribution of over 43% in 2026. Despite a relatively lower CAGR over 2016-2026, this segment will be evaluated at around US$ 107 Mn in 2026.
35-50 metre segment will retain the second largest segment position with estimated revenue sales worth US$ 80 Mn in 2026, capturing over 31% share of the market value. This segment is expected to demonstrate the fastest growth at a CAGR of 5.6%.
Based on country, GCC will continue its monopoly with over 60% value share by the end of forecast period, eventually approaching US$ 150 Mn by 2026 end.
South Africa and Israel will be the next largest markets, whereas the rest of MEA and Turkey will witness higher growth rates of over 7%.

Market segmentation

To understand and assess opportunities in the Middle East and Africa rough terrain cranes market, we have divided the report into four sections based on market segmentation as under:

By Lifting Capacity

Upto 25 Tonnes
25.1 to 50 Tonnes
50.1-75 Tonnes
75.1-100 Tonnes
More than 100 Tonnes

By Boom Length

Upto 25 meters
25.1-35 meters
35.1-50 meters
More than 50 meters

By Sales Channel

New Sales
Equipment Rental

By Country

GCC
Israel
Turkey
South Africa
Northern Africa
Rest of Middle East and Africa

Direct Purchase of this Report@ https://www.futuremarketinsights.com/checkout/2571

MEA Rough Terrain Cranes Market – New Sales

This market, according to Future Market Insights, will account for the revenues of nearly US$ 142 Mn by 2026-end.

By lifting capacity, 50-75T capacity segment is projected to attract the maximum revenues.
75-100T capacity segment is likely to account for over 28% market value share in 2026.
> 100T capacity segment is predicted to witness the highest CAGR resulting in almost exponential growth in sales revenues over 2016-2026.
In terms of boom length, 25-35 metre segment will continue to dominate through 2026, accounting for more than 43% value share.
> 50 metre segment will be the fastest growing segment, exhibiting an impressive CAGR of 6.7%, resulting into twofold growth of the market over 2016-2026.
Country-wise, GCC will retain dominance, followed by South Africa. While the former is foreseen to attract over US$ 81 Mn in terms of 2026 revenues, the latter will reach over US$ 20 Mn in 2026.
GCC reaffirms the leading position with around 58% value share in 2026, whereas the rest of MEA, North Africa, and Turkey are expected to witness higher CAGRs over the assessment period.

Among the leading players in the MEA rough terrain cranes market, Terex Corporation is identified to hold the most prominent share of over 21% in terms of new sales. Other leading companies include The Manitowoc Company, Inc., Tadano Ltd., Zoomlion Heavy Industry Science And Technology Co., Ltd., Liebherr Group, Xuzhou Construction Machinery Group Co., Ltd., Sany Heavy Industry Co., Ltd., and KATO WORKS CO., LTD.